Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BFI Finance Indonesia Tbk (BFIN) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

BFI Finance Indonesia TbkTrade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

BFI Finance Indonesia Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? BFI Finance Indonesia Tbk trades at Rp915 (market cap 13.76T, 29.96M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: BFI Finance Indonesia Tbk is far larger — about 43.5× Diagnos Laboratorium Utama Tbk.'s market cap, and BFI Finance Indonesia Tbk is more actively traded (29.96M versus 41.7K). Which is the better fit depends on your goals.

BFINDGNS
Market Cap
13.76T316.25B
Volume
29.96M41.7K
Lot
299.63K417
Turnover
27.08B9.66M
Average Price
903.88231.65
Value
27.08B9.66M
Indicative Equilibrium Price
915230
Indicative Equilibrium Volume
2.26K2.4K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BFIN
View details
DGNS
View details

About BFI Finance Indonesia Tbk

PT BFI Finance Indonesia Tbk (the Company) formerly PT. Bunas Finance Indonesia Tbk (the Company) was established as PT Manufacturers Hanover Leasing Indonesia on April 7, 1982 based on Notarial deed No. 57 of Kartini Muljadi, S.H., Notary in Jakarta. Presently, the Company is engaged in leasing, consumer financing and factoring of accounts receivable. And changed to BFI Finance Indonesia on 2001

Read more on BFIN

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS